Matinas Biopharma Holdings Inc (MTNB)
AMEX
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 1.06M | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.48M | -5.59M | -6.16M | -6.13M | -5.89M | -5.9M | -5.84M | -4.38M |
Pre Tax Income | -3.64M | -5.51M | -6.06M | -6.06M | -5.31M | -5.82M | -5.72M | -4.28M |
Net Income | -3.64M | -5.51M | -6.06M | -6.06M | -5.31M | -5.82M | -5.72M | -4.28M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -7.92M | -5.51M | -6.06M | -6.06M | -5.8M | -5.82M | -5.72M | -4.28M |
EBITDA | -5.4M | -5.49M | -6.06M | -6.04M | -5.79M | -5.81M | -5.75M | -4.29M |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 150k | 120k | 90k | 158k | 33k | 3.19M | 1.1M |
Operating Income | -16.5M | -14.65M | -18.92M | -24.21M | -24.74M | -24.59M | -23.77M |
Pre Tax Income | -15.84M | -14.59M | -17.37M | -22.45M | -23.28M | -21M | -22.94M |
Net Income | -32.84M | -14.99M | -18.3M | -23.24M | -23.68M | -21M | -22.94M |
Preferred Dividends | -608k | -905k | -924k | -793k | -396k | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.352 | -0.132 | -0.112 | -0.116 | -0.109 | -0.097 | -0.106 |
EBIT | -15.84M | -14.59M | -18.38M | -23.52M | -24.61M | -24.49M | -23.43M |
EBITDA | -16.4M | -14.43M | -18.14M | -23.98M | -24.49M | -24.25M | -23.38M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.